Judge denies request by ‘delusional’ Martin Shkreli to be released for COVID-19 research

Nation/world
Former pharmaceutical executive Martin Shkreli speaks to the press after the jury issued a verdict in his case at the U.S. District Court for the Eastern District of New York in Brooklyn on Aug. 4, 2017. (Credit: Drew Angerer / Getty Images)

Former pharmaceutical executive Martin Shkreli speaks to the press after the jury issued a verdict in his case at the U.S. District Court for the Eastern District of New York in Brooklyn on Aug. 4, 2017. (Credit: Drew Angerer / Getty Images)

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

A judge has rejected convicted pharmaceutical executive Martin Shkreli’s request to be let out of prison to research a coronavirus treatment.

U.S. District Judge Kiyo Matsumoto noted that probation officials viewed that claim as the type of “delusional self-aggrandizing behavior” that led to his conviction.

Matsumoto wrote in a nine-page ruling Saturday that the man known as the “Pharma Bro” failed to demonstrate extraordinary and compelling factors that would require his release under home confinement rules designed to move vulnerable inmates out of institutions during the pandemic.

Shkreli is serving a seven-year prison sentence for a 2017 conviction.

Most Popular

Latest News

More News